Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
February 4, 2019
Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14
DUBLIN, Ireland, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage neuroscience company, announced today that it will report its fourth quarter ...
February 1, 2019
What is a Non Deal Roadshow? Strong relationships with investors usually lead to more profitable investments. The big question is, how can these relationships be ...
January 31, 2019
VALNEVA Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate
Saint-Herblain (France), January 31, 2019 - Valneva SE ("Valneva"), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, today announced ...
January 31, 2019
Fortress Biotech Announces CAEL-101 Strategic Partnership with Alexion Pharmaceuticals
NEW YORK, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and ...
January 31, 2019
Entera Bio Announces Positive Feedback and Guidance from the US FDA Regarding its Development Plans for Oral PTH in Osteoporosis
JERUSALEM, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX), announced today the positive outcome of a pre-IND meeting held with the US Food ...
January 31, 2019
Catalyst Biosciences Announces Oral and Poster Presentations at the 12th Annual Congress of the European Association for Haemophilia and Allied Disorders
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
January 31, 2019
Zosano Announces Publication of Positive Data on Qtrypta’s™ Potential as an Acute Treatment for Patients with Difficult-to-Treat Migraines
FREMONT, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced the peer-reviewed publication ...
January 31, 2019
Genkyotex Provides Corporate Update and Reports Cash Position at December 31, 2018
Genkyotex (Euronext Paris & Brussels: FR0011790542 – GKTX) (GKTX.PA) (GKTX.PA), a biopharmaceutical company and the leader in NOX therapies, today provided a corporate update, and ...
January 31, 2019
Quantum Genomics Presents its 2019 Corporate Action Plan
PARIS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug ...
January 31, 2019
Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Blue Cross Blue Shield of North Carolina
MINNEAPOLIS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
January 30, 2019
AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer’s Disease
LAUSANNE, Switzerland, Jan. 30, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (ACIU) announced today that Roche, the parent company of its collaboration partner, is discontinuing ...
January 30, 2019
Orphazyme reports positive results from full data set of Phase II/III arimoclomol trial in Niemann-Pick disease Type C (NPC)
Copenhagen, January 30, 2019 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced the full data set ...
January 30, 2019
BioInvent Receives FDA Orphan Designation for BI-1206 for Mantle Cell Lymphoma
LUND, Sweden, Jan. 30, 2019  /PRNewswire/ -- BioInvent International AB (OMXS:BINV) announces today that the U.S. Food and Drug Administration (FDA) has granted the Company ...
January 30, 2019
Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its ...
January 30, 2019
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Research and Development
REHOVOT, Israel, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, announced today the appointment of Michal ...
January 30, 2019
Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina
VANCOUVER , Jan. 30, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve ...
January 30, 2019
Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials
Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today provided ...
January 30, 2019
Cormedix Inc. Announces Topline Analysis of the Full Data Set of Phase 3 Lock-It-100 Study Reinforces the Interim Results
BERKELEY HEIGHTS, NJ / ACCESSWIRE / January 30, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
January 30, 2019
aTyr Pharma Announces Research Collaboration with the University of Nebraska Medical Center and Expansion of Successful Pilot Study
SAN DIEGO, Jan. 30, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based ...
January 29, 2019
INNATE PHARMA RECEIVES FDA FAST TRACK DESIGNATION FOR IPH4102 IN RELAPSED OR REFRACTORY SÉZARY SYNDROME
Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) announced today that the US Food and Drug Administration (FDA) has granted Fast Track ...
Page 17 of 138